Atlas Trials

Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer

RecordFirmDate
A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer) (NCT04576455)Hoffmann-La Roche2020-11-27

Track Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer automatically

Every clearance here is in the API, with alerts when new ones post.